SC Pharmaceuticals Inc (SCPH) Stock Price, Quote & News

Company Profile

scPharmaceuticals Inc., a pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for the treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresi...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 517 0730

Website: www.scpharmaceuticals.com

Address:

25 Mall Road, Suite 203, Burlington, United States

clan Oct. 4 at 9:37 AM

$MNKD The pieces to the Mannkind puzzle are coming together ... and it's makin' fer a pretty nice lookin' picture!🧩💲🧩💲 $SCPH $UTHR $BX

1 · Reply

Tom678 Oct. 2 at 12:02 PM

$BCDA $DJT $PAVS $SCPH $TAOP BCDA amazing news !!!! 😁😁

0 · Reply

Zeroletdown Oct. 2 at 1:32 AM

$SCPH So bit confused. If I'm in the stock for the full payout, 3.35 plus extra $1, should I tender my shares at 5.35 And rest comes later? Or hold? Thx

2 · Reply

TwongStocks Oct. 1 at 6:48 PM

$SCPH NASDAQ Equity Corporate Actions Alert # 2025 - 542 Information Regarding the Tender Offer of scPharmaceuticals Inc. (SCPH) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-542 The tender offer by Seacoast Merger Sub, Inc. a direct wholly owned subsidiary of MannKind Corporation $MNKD to acquire all of the outstanding common stock of scPharmaceuticals Inc. (SCPH) is scheduled to expire one minute after 11:59 p.m. ET, on October 6, 2025, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on October 7, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on October 6, 2025. If the merger closes as planned, the stock will remain halted on the day of closing (October 7, 2025) and will be suspended effective October 8, 2025. Tender offer: SCPH shareholders will receive $5.35 and one (1) Contingent Value Right (CVR) for each share held.

0 · Reply

nomalarkey Oct. 1 at 1:46 PM

uh, @StockHounding , $MNKD announced it was buying $SCPH back in August. How exactly did you miss that key news?

0 · Reply

clan Sep. 30 at 4:22 PM

$MNKD $SCPH More of this coming...

0 · Reply

clan Sep. 30 at 2:50 PM

$SCPH @neil36. With this stock selling at a current $0.31/sh premium to the tender offer of $5.35/sh ( by $MNKD ), it appears 'Vegas' odds are leaning toward all the current shareholders of scPharma will get the full $1 per CVR issued. A win-win-win for all. 💎👐

1 · Reply

StockHounding Sep. 28 at 6:18 PM

$BCDA big moves soon $SCPH chart looks like a buyout or something $TAOP bottom for now $PAVS lots of momentum. This is likely a top runner on MONDAY. 🔥🔥🔥 $DJT going up soon

1 · Reply

clan Sep. 27 at 9:10 PM

$MNKD Expecting a couple October "Yabba Dabba Doo!" moments for Mannkind. 🎃👻 $SCPH $UTHR

0 · Reply

ChartChartist Sep. 27 at 5:28 PM

$SAVA downchannel gonna break retest $3.5 $SCPH looks tight $CCCX up $PAVS everyone’s going crazy slapping pavs i love to see it perfect setup be on it

1 · Reply

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH

MNKD

Aug 25, 2025, 7:31 AM EDT - 5 weeks ago

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

Aug 14, 2025, 8:30 AM EDT - 7 weeks ago

scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111

Aug 8, 2025, 2:09 PM EDT - 2 months ago

scPharmaceuticals Inc. (SCPH) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:01 PM EDT - 2 months ago

scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 31, 2025, 4:01 PM EDT - 2 months ago

scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025

May 22, 2025, 7:29 AM EDT - 4 months ago

scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025

May 15, 2025, 12:15 AM EDT - 5 months ago

scPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:01 PM EDT - 5 months ago

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

May 7, 2025, 4:01 PM EDT - 5 months ago

scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025

May 1, 2025, 4:01 PM EDT - 5 months ago

scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences

Mar 19, 2025, 7:13 PM EDT - 7 months ago

scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 4:01 PM EDT - 7 months ago

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 12, 2025, 4:01 PM EDT - 7 months ago

scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

Mar 6, 2025, 4:01 PM EST - 7 months ago

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

Feb 26, 2025, 4:01 PM EST - 7 months ago

scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences

Feb 5, 2025, 4:01 PM EST - 8 months ago

scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 10, 2025, 8:00 AM EST - 9 months ago

scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

Nov 13, 2024, 7:05 PM EST - 11 months ago

scPharmaceuticals Inc. (SCPH) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 11 months ago

scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 6, 2024, 4:01 PM EST - 11 months ago

scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

Oct 15, 2024, 8:30 AM EDT - 1 year ago

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024

Aug 15, 2024, 5:10 AM EDT - 1 year ago

scPharmaceuticals Inc. (SCPH) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 12, 2024, 9:48 AM EDT - 1 year ago

scPharmaceuticals Announces Pricing of $50.0 Million Public Offering

Aug 12, 2024, 6:05 AM EDT - 1 year ago

scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors

Aug 12, 2024, 6:04 AM EDT - 1 year ago

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure

Aug 12, 2024, 6:02 AM EDT - 1 year ago

scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector

Aug 12, 2024, 6:00 AM EDT - 1 year ago

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

May 29, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 14, 2024, 7:02 PM EDT - 1 year ago

scPharmaceuticals Inc. (SCPH) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

May 13, 2024, 4:05 PM EDT - 1 year ago

scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 7, 2024, 4:05 PM EDT - 1 year ago

scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Apr 24, 2024, 8:00 AM EDT - 1 year ago

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

Mar 13, 2024, 7:32 PM EDT - 1 year ago

scPharmaceuticals Inc (SCPH) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Mar 6, 2024, 4:01 PM EST - 1 year ago

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

Feb 28, 2024, 4:01 PM EST - 1 year ago

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

Jan 4, 2024, 4:05 PM EST - 1 year ago

scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue

Nov 12, 2023, 2:57 AM EST - 2 years ago

scPharmaceuticals Q3 Earnings: Cruising Toward Success

Nov 8, 2023, 9:58 PM EST - 2 years ago

scPharmaceuticals Inc (SCPH) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:01 PM EST - 2 years ago

scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 1, 2023, 4:05 PM EDT - 2 years ago

scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

Oct 5, 2023, 8:00 AM EDT - 2 years ago

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 27, 2023, 12:40 AM EDT - 2 years ago

scPharmaceuticals: Furoscix, Charting A Bright Future With FDA's Nod For CKD

Sep 19, 2023, 8:00 AM EDT - 2 years ago

scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives

clan Oct. 4 at 9:37 AM

$MNKD The pieces to the Mannkind puzzle are coming together ... and it's makin' fer a pretty nice lookin' picture!🧩💲🧩💲 $SCPH $UTHR $BX

1 · Reply

Tom678 Oct. 2 at 12:02 PM

$BCDA $DJT $PAVS $SCPH $TAOP BCDA amazing news !!!! 😁😁

0 · Reply

Zeroletdown Oct. 2 at 1:32 AM

$SCPH So bit confused. If I'm in the stock for the full payout, 3.35 plus extra $1, should I tender my shares at 5.35 And rest comes later? Or hold? Thx

2 · Reply

TwongStocks Oct. 1 at 6:48 PM

0 · Reply

nomalarkey Oct. 1 at 1:46 PM

uh, @StockHounding , $MNKD announced it was buying $SCPH back in August. How exactly did you miss that key news?

0 · Reply

clan Sep. 30 at 4:22 PM

$MNKD $SCPH More of this coming...

0 · Reply

clan Sep. 30 at 2:50 PM

1 · Reply

StockHounding Sep. 28 at 6:18 PM

$BCDA big moves soon $SCPH chart looks like a buyout or something $TAOP bottom for now $PAVS lots of momentum. This is likely a top runner on MONDAY. 🔥🔥🔥 $DJT going up soon

1 · Reply

clan Sep. 27 at 9:10 PM

$MNKD Expecting a couple October "Yabba Dabba Doo!" moments for Mannkind. 🎃👻 $SCPH $UTHR

0 · Reply

ChartChartist Sep. 27 at 5:28 PM

$SAVA downchannel gonna break retest $3.5 $SCPH looks tight $CCCX up $PAVS everyone’s going crazy slapping pavs i love to see it perfect setup be on it

1 · Reply

clan Sep. 27 at 2:01 PM

It'd be cray-Z for holders of $SCPH to NOT roll their cash into $MNKD after the closing of the merger.

0 · Reply

clan Sep. 27 at 12:22 AM

$MNKD Verde. Green. Good. $SCPH about to jump on board.

0 · Reply

clan Sep. 26 at 2:11 PM

$MNKD APPROVALS {and eventual accretive} ADDS TO MNKD SHARE PRICE [B4 EOY 2028]: + $3 -- acquisition of scPharma/Furoscix [ $SCPH ] + $5 -- FDA approval of Furoscix auto injector + $9 -- pediatric Afrezza + $3 -- gestational Afrezza + $6 -- 2nd Unither DPI drug [ $UTHR ] + $7 -- Clofazimine nebulized (CIS) + $4 -- Clofazimine DPI +$11 -- Nintedanib DPI + $3 -- TYVASO for IPF + $6 -- TYVASO for PPF 💎👐

0 · Reply

Zeroletdown Sep. 25 at 3:43 PM

$SCPH so this one will pay out roughly 12 to 13% within one year? That's not a bad return considering money market funds / savings account are paying a little bit over 4% now... and going down.

1 · Reply

clan Sep. 25 at 11:28 AM

$MNKD Can I also borrow $10M? "... On September 23, 2025, Parent [Mannkind] loaned $10.0 million to the Company [ $SCPH ] pursuant to an Unsecured Promissory Note, dated as of September 23, 2025 and issued by the Company to Parent..."

0 · Reply

clan Sep. 24 at 1:24 PM

$MNKD New 52-week highs and double-digits are coming... Spurred by $SCPH shareholders rolling their cash into MNKD. 🐂

0 · Reply

clan Sep. 22 at 10:02 PM

$MNKD @neil36 @MrMulally @MayorofMNKD @OleBob If you want 20 mins of insightful and interesting reading on the last 7 months attempt of scPharma ["Company"] trying to attract an offer to be purchased (by Mannkind ["Parent"]) you should read pages 15 to 25 of scPharma's 14-D9 filing. Here's the link: ---> ir.scpharmaceuticals.com/no... To make the read really interesting, you should reference $SCPH 's daily stock price movement as you read along the chronological events. I speculate the 2 disgruntled "shareholders" of SCPH who filed the recent lawsuits are part of "Party A" that dikked around too long, low-balling an offer. This read also gives some interesting insight on Lasagna, Binder, and Prentiss

1 · Reply

Fortfr Sep. 22 at 11:06 AM

$SCPH Can someone please explain what’s happening with this company please ? Is it being bought by Mankind ?

1 · Reply

clan Sep. 21 at 1:22 PM

$MNKD Binder has been a busy little ... 🦫 For the good of all Mannkind ... ... and $UTHR and $SCPH and $BX and ... tbd.

0 · Reply

clan Sep. 19 at 4:51 PM

$SCPH If you question the likelihood of a shareholder of SCPH (as of merger closing date) getting the full $1 in a year, for the CVR they will receive (shortly), just look at the >52M shares of scPharma currently held at a $0.28/sh premium [$5.63 (current) - $5.35 (buyout)], knowing the holders will likely have to wait a whole year to get their $1. A great bet; $0.28 now for $1 in a yr. Bodes well for the promise and belief in $MNKD . MNKD26In26!

0 · Reply

clan Sep. 19 at 11:50 AM

$MNKD ~ Mannkind happenings to come ~ 2025: 💲9/28 - Teton 2 update 💲FDA accepts SNDA Furoscix autoinjector 💲Oct. - $SCPH closing 💲Inhale-1 (kids) results / FDA filing 💲Afrezza applic. submission for pregs 💲Oct - FDA approval Afrezza dosing label 💲Clofazimine trial fully enrolled (100) 💲Nov ~5th ISPAD conf (kids Afrezza) 💲Nov ~7th Earnings 3Q w/ record Revs 💲2nd $UTHR molecule announced 💲FDA accepts pediatric sBLA 💲Afrezza ships to India 💲Expanded Afrezza Sales force and campaign 💲Nintedanib Ph 2 trial start (IPF) ~ Early 2026 ~ 💰Afrezza rollout India & US re-launch 💰Feb ~26th Earnings 4Q w/ record Revs 💰US Afrezza TRx > 1K/wk 💰Mar - ATTD conference 💰Mar - Oppenheimer conf. 💰Teton 1 (US) results 💰INHALE AID Ex trial results 💰Clofaz. (ICON-1) readout 💰Tyvaso DPI bridge study IPF 💰May ~12th Earnings 1Q w/ record Revs 💰May FDA approval Afrezza kids! 💰FDA approval Furoscix autoinjector . . .

0 · Reply

uscharalph Sep. 19 at 11:24 AM

$SCPH Do you think we will get all of the $1 CVR or will they screw us there too?

1 · Reply

Market Cap	301.67M
Revenue (ttm)	36.33M
Net Income (ttm)	-85.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-234.38%
Debt to Equity Ratio	-2.40

Volume	3,811,200
Avg Vol	1,543,688
Day's Range	N/A - N/A
Shares Out	53.30M
Stochastic %K	75%
Beta	0.31
Analysts	Sell
Price Target	$11.84